gilead hiv - Search News

News

FDA Approves HIV Shot That’s 99.9% Effective

FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag

Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over its $28K annual price.

CNBC on MSN · 1d

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

USA TODAY on MSN · 19h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

31mon MSN

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

The BMJ40m

“Hard to justify” $28 000 price tag for breakthrough HIV prevention treatment, says UN agency

A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...

3don MSN

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

The Independent1h

UNAIDS urges Gilead to drop price of new HIV prevention drug

The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results